Purpose: The statistical screening of pharmacovigilance databases containing spontaneously reported adverse drug reactions (ADRs) is mainly based on disproportionality analysis. The aim of this study was to improve the efficiency of full database screening using a prediction modelbased approach.
historically relied on a case-by-case clinical review of incoming reports, directly submitted by health care professionals (HCP) and consumers. This review is performed by trained pharmacovigilance assessors, the majority of them being medical doctors and pharmacists. Reports that may represent a potential signal in the view of the assessor are discussed in a weekly scientific meeting. Potential signals undergo a more detailed analysis. 4 Lareb has criteria in place for assessors to determine which reports should be discussed at the weekly scientific meeting. However, because multiple assessors are involved in this process and the selection of reports for the weekly scientific is prone to some level of subjectivity, a computer-assisted database screening tool is in place as an additional approach to reduce the risk for missing potential signals. 5 The screening tool is even more important for ADRs reported by marketing authorization holders (MAHs) that may be indicative of potential signals, as these are not assessed on a case-by-case basis at Lareb.
The computer-assisted database screening tool used in the Netherlands relies on the number of reports of drug-ADR associations and disproportionality based on the reporting odds ratio (ROR). With the disproportionality analyses, the observed rate of a drug and ADR together is compared with an expected value based on their relative frequencies reported individually in the spontaneous reporting database. 5, 6 In the approach applied at our centre, the lower limit of the 2-sided 95% confidence interval (CI) is used combined with a number of at least 3 reports per association. Associations can be automatically selected by the screening tool based on 1 or more of the following predefined criteria; Anatomical Therapeutic Chemical code (allowing the assessor to screen more efficiently), ADR being unlabeled in the Summary of Product Characteristics (SPC), number of reports (≥3), threshold of the lower limit of the 2-sided 95% CI of the ROR (ROR025) (>1), pre-specified calendar date, set during previous analysis. Associations highlighted by the screening tool undergo a short analysis by trained pharmacovigilance assessors. Based on the decision of the assessor, subsequent new thresholds can be specified (ADR, unlabeled, number of reports or lower limit 95% CI, new date) or the association can undergo further detailed analyses. The association will be highlighted again as soon as one of the aforementioned criteria is met. 7 Although the current approach facilitates the selection of potential signals, the downside of this approach is that it yields a high number of associations that need an initial, short analysis, which is a 
KEY POINTS
• Current methods for full database screening of ADRs are mainly based on disproportionality, which has its limits due to its sensitivity for several types of selection bias.
• We developed a prediction model-based approach to generate a priority list of drug-ADR associations to be analyzed.
• The performance of the model and the comparison with the current method showed that the prediction modelbased approach is to be preferred over the current method.
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| Outcome
The outcome of the model was defined as the presence in the SPC of each unique drug-ADR association at the time of the analysis.
Although the use of the SPC to determine if an association is actually an ADR (implying causality) has its limitations, it has been used in several studies aimed at statistical signal detection. 13, 14 At Lareb, for each association present in an ICSR received directly from a HCP or consumer, a causality assessment using the Naranjo score is performed. 
| Inclusion / exclusion criteria
All reports received until 12-May-2016 were considered eligible for inclusion with the exception of reports related to vaccines. For these reports, a method other than Naranjo is used to determine causality.
Because that particular method lacks information about the presence in the SPC, reports related to vaccines were excluded. For statistical considerations, only associations with a minimum of 3 reports were selected, because this was deemed to be the minimum number of reports needed for a reliable ROR estimation.
| Selection of candidate predictors
For each association, the following variables were selected as candidate predictors in the model:
1. The number of ICSRs.
2. The lower limit of the 2-sided 95%CI of the ROR (ROR025).
3. ).
5. The mean Naranjo score across all reports containing the association. The answer to question 1 was excluded in the calculation of the Naranjo score because this question is the basis for the outcome variable of the prediction model. Additionally, because no Naranjo scores are present for MAH reports, scores for those reports were set at +2 because we considered it valid to assume that the ADR occurred after the suspect drug was given (Naranjo question 2). Table 1 . Median values with interquartile ranges (IQR) and proportions of the candidate predictors are shown in Table 2 .
Prior to the regression analysis, all candidate predictors were divided into 4 categories of equal sizes due to non-linearity. After the backward step-wise selection procedure, all candidate predictors were included into the final model. VIF values for the assessment of multicollinearity were below the pre-defined threshold (4) for all predictors in the model. The proportion of associations present in the SPC increased with increasing numbers of reports and an increasing proportion of HCP reports. For ROR025, Naranjo score and proportion of MAH reports the direction of the effect was less consistent. For ROR025, an increase in category was associated with increasing coefficients except for the highest category. For both Naranjo and MAH reports, the lower categories were associated with a higher coefficient (see also Table 3 ). 
| Performance and validation
The performance of the model was satisfactory, based on the area under the receiver operating characteristic curve (AUC = 0.740; 95%CI 0.734-0.747; see Figure 1 ). The 3 strongest predictors in the model were more than 8 reports per association, followed by a percentage of HCP reports of 75% or higher, and a percentage of MAH reports between 0% and 20% (see Table 3 ).
The calibration curve of the model shows good calibration based on the observed versus predicted probabilities (see Figure 2) . Addition- (from 12.3% to 19.4%) and 44.2% (from 9.6% to 13.9%) depending on the number of associations used (800 vs 1600, respectively). Additional information is present in Table 4 .
| DISCUSSION
In this study, we developed a prediction model-based screening tool aimed at improving statistical signal detection of our spontaneous ADR reports. Five relevant characteristics (number of reports, disproportionality, Naranjo score, proportion MAH reports, proportion HCP reports) were chosen as potential predictors in the model. For
Naranjo, we considered to use the scoring (doubtful, possible, probable, definite) for categorization. However, this would result in a skewed distribution of observations due to the (very) low numbers of associations with outcome "definite". Our choice to set the Naranjo score for all MAH reports to +2 was based on the assumption that the ADR occurred after the suspect drug was given, which gives a score of +2. Because no case-by-case assessment is performed for MAH reports at our centre, other items from the Naranjo algorithm could not be answered. This approach could lead to less diversity in the Naranjo scores, and as a result impact the performance of the model. However, a recent pilot study performed at our centre investigating case-by-case analysis of MAH reports showed that the documentation level of the reports was often poor. 20 Therefore, availability of information on additional Naranjo items would most likely be limited. Although important in statistical signal detection, 13, 21 the time to onset was not included as a predictor in our model. In a previous study, we investigated the values of the time to onset in statistical signal detection and found that it was of limited value in the investigated setting. 22 Overall, the model performed well (AUC = 0.740) and showed good calibration. The highly significant result of the HosmerLemeshow test (P < 0.001), indicating a poor goodness of fit, is most likely explained by the large sample size and should be interpreted with caution. 23 Based on the calibration curve and the bootstrap resampling, the internal validation was considered satisfactory. The latter showed a negligible difference in AUC (0.740 versus 0.739).
We found little differences in AUC values among individual predictors, although disproportionality (ROR025) seems to have the lowest predictive value. This may be explained by the fact that disproportionality is sensitive to selective reporting and other types of bias. [24] [25] [26] Within subgroups of predictors, we found some noteworthy results regarding the regression coefficients. The predictors "number of reports" and "percentage of HCP reports" showed a consistent increase in coefficients with increasing categories, which was as expected. For ROR025 and Naranjo, we anticipated similar results, which was not the case though (see Table 3 ). This may be explained by the fact that the outcome used in our model (presence of the association in the SPC) does not by definition imply causality because true
ADRs are not necessarily present in this document, and on the other hand, events that are not true ADRs may be present. Additionally, the categories used for Naranjo in the model limit the conclusions that can be drawn from the regression coefficients. For fitting of the model, 4 more or less equally sized categories were made due to non-linearity of the parameter. As a result, the first 3 categories range from 0 to 2, and the fourth category contains all values above 2, whereas the actual Naranjo score has a range from −4 till 13. For the percentage of MAH reports, there seems to be an inverse relationship with presence in the SPC. One striking difference between MAH reports and reports received directly from HCPs or consumers that we found in our previously described pilot study 20 used as a reference set of positive controls. 8 However, the issue regarding causality and presence in the SPC as mentioned earlier remains, because they used the SPC to define the negative controls.
We considered it more appropriate to use the same gold standard for both the positive and negative controls and therefore decided to use the SPC for both. Additionally, the use of a reference set would most likely result in a less heterogeneous set of ADRs because it would probably not contain more common ADRs (eg, headache, dizziness, nausea, etc.), although these types of ADRs are among the most frequently present in spontaneous reports.
The linear predictor-based priority lists comparing the old and new model showed a substantial increase in potential signals among the most highly ranked drug-ADR combinations not present in the SPC.
In this context, the increase in potential signals should be seen in terms or earlier detection due to prioritization and not in terms of signals that would, or would not be picked up by either method.
Previous research suggests that results obtained from signal detection algorithms depend on the database the algorithm is applied to. 8, 19 The same will hold for our algorithm. For example, in the Netherlands, we receive a substantial amount of ICSRs reported by patients, but this is not necessarily the case in other countries. Therefore, the use of the amount of HCP reports as a candidate predictor may not be a logical choice for other databases. Consequently, the development of such a model should be based on the reporting and database characteristics of the country or region it is applied to.
Nevertheless, the method of generating a prediction model-based priority list of signals could be useful in other (spontaneous reporting) databases.
One of the limitations of our study is the risk of bias due to selective reporting. Because the database contains well-established associations, it is reasonable to assume that these associations are reported more frequently than unknown associations, therewith influencing the predictors in the model. In an alternative approach, the values of the predictors immediately prior to the recognition of the association could be used in the model. However, recovering the date of recognition for several thousand associations may prove to be infeasible.
In conclusion, this study shows that a prediction model-based screening tool can be used to generate priority-based listings of drug-ADR associations for signal detection. Additionally, as seen in other studies, 8, 27 the introduction of variables other than the number of reports and disproportionality can increase screening efficiency due to priority-based assessment of drug-ADR associations.
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